SCHEMBL5226944

SCHEMBL5226944

CCCN1CCCCC[C@H]1C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
KCNK3 O14649 1/20 0.52
LMNA P02545 1/20 0.52
SMN1; SMN2 Q16637 3/20 0.46
SLC6A1 P30531 4/20 0.45
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
KCNH2 Q12809 1/20 0.43
POLB P06746 1/20 0.43
TSHR P16473 1/20 0.43
NR1I2 O75469 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28152186 1.00 KCNK3 (0.52) KCNK3LMNASMN1; SMN2SLC6A1CYP3A4
SCHEMBL669604 0.98 KCNK3 (0.54) KCNK3LMNASMN1; SMN2SLC6A1CYP3A4
SCHEMBL23551811 0.98 KCNK3 (0.54) KCNK3LMNASMN1; SMN2SLC6A1CYP3A4
SCHEMBL28148146 0.98 KCNK3 (0.54) KCNK3LMNASMN1; SMN2SLC6A1CYP3A4
Hydrochloric Acid SCHEMBL28151982 0.96 KCNK3 (0.52) KCNK3LMNASMN1; SMN2SLC6A1CYP3A4
SCHEMBL3145758 0.93 LMNA (0.48) KCNK3LMNASMN1; SMN2SLC6A1NR1I2
SCHEMBL1887364 0.93 LMNA (0.48) KCNK3LMNASMN1; SMN2SLC6A1NR1I2
SCHEMBL1887361 0.93 LMNA (0.48) KCNK3LMNASMN1; SMN2SLC6A1NR1I2
Hydrochloric Acid SCHEMBL9155039 0.91 LMNA (0.47) KCNK3LMNASMN1; SMN2SLC6A1CYP3A4
Hydrochloric Acid SCHEMBL9155025 0.91 LMNA (0.47) KCNK3LMNASMN1; SMN2SLC6A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1814893-A2 NOVEL LINCOMYCIN DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY Vicuron Pharmaceuticals, Inc. (US) 2007-08-08 EP disclosed
WO-2006055070-A2 NOVEL LINCOMYCIN DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY VICURON PHARMACEUTICALS INC. (US) 2006-05-26 WO disclosed